Gulsun Erdag

Summary

Publications

  1. ncbi request reprint Cavernous hemangioma of tunica albuginea testis manifesting as testicular pain
    Gulsun Erdag
    Department of Pathology, Lenox Hill Hospital, New York, New York, USA
    Urology 68:673.e13-5. 2006
  2. ncbi request reprint Immunoglobulin A pemphigus involving the perianal skin and oral mucosa: an unusual presentation
    Gulsun Erdag
    Department of Pathology, Georgetown University Medical Center, Washington, DC 20007, USA
    Cutis 80:218-20. 2007
  3. doi request reprint CD34-positive dendritic cells disappear from scars but are increased in pericicatricial tissue
    Gulsun Erdag
    Department of Pathology, Georgetown University Medical Center, Washington, DC 20007, USA
    J Cutan Pathol 35:752-6. 2008
  4. doi request reprint A case of pityriasis rubra pilaris with associated focal acantholytic dyskeratosis complicated by Kaposi's varicelliform eruption
    Gulsun Erdag
    Section of Dermatopathology, Department of Pathology, University of Virginia, Charlottesville, VA, USA
    J Cutan Pathol 38:919-22. 2011
  5. pmc Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47)
    Craig L Slingluff
    University of Virginia, Charlottesville, VA 22908, USA
    Clin Cancer Res 19:3611-20. 2013
  6. pmc Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma
    Gulsun Erdag
    Department of Pathology, University of Virginia, Charlottesville, Virginia 22908, USA
    Cancer Res 72:1070-80. 2012
  7. doi request reprint Locally invasive dermal squamomelanocytic tumor with matrical differentiation: a peculiar case with review of the literature
    Nemanja Rodic
    Department of Pathology, Johns Hopkins Hospital, Baltimore, MD 21205, USA
    Am J Dermatopathol 35:e72-6. 2013
  8. ncbi request reprint Solitary fibrous tumors of the skin: a clinicopathologic study of 10 cases and review of the literature
    Gulsun Erdag
    Department of Pathology, Georgetown University Medical Center, Washington, DC, USA
    J Cutan Pathol 34:844-50. 2007
  9. pmc VEGFR-2 expression in human melanoma: revised assessment
    Kerrington R Molhoek
    Department of Surgery, University of Virginia School of Medicine, Charlottesville, VA, USA
    Int J Cancer 129:2807-15. 2011

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Cavernous hemangioma of tunica albuginea testis manifesting as testicular pain
    Gulsun Erdag
    Department of Pathology, Lenox Hill Hospital, New York, New York, USA
    Urology 68:673.e13-5. 2006
    ..Both cases presented as testicular masses. We report what we believe to be the third case of cavernous hemangioma of the tunica albuginea that manifested as pain without any mass...
  2. ncbi request reprint Immunoglobulin A pemphigus involving the perianal skin and oral mucosa: an unusual presentation
    Gulsun Erdag
    Department of Pathology, Georgetown University Medical Center, Washington, DC 20007, USA
    Cutis 80:218-20. 2007
    ..We report an unusual case of IgA pemphigus involving anal/ perianal skin and oral mucosa that demonstrated a successful response to dapsone treatment...
  3. doi request reprint CD34-positive dendritic cells disappear from scars but are increased in pericicatricial tissue
    Gulsun Erdag
    Department of Pathology, Georgetown University Medical Center, Washington, DC 20007, USA
    J Cutan Pathol 35:752-6. 2008
    ..One should be aware that augmented labeling for CD34SC around scars is common; it should not be interpreted as evidence for the persistence or recurrence of tumors that may also express CD34...
  4. doi request reprint A case of pityriasis rubra pilaris with associated focal acantholytic dyskeratosis complicated by Kaposi's varicelliform eruption
    Gulsun Erdag
    Section of Dermatopathology, Department of Pathology, University of Virginia, Charlottesville, VA, USA
    J Cutan Pathol 38:919-22. 2011
    ..We report a patient with PRP whose biopsies showed both herpes simplex infection and FAD. A complete understanding of the mechanism behind this eruption evolved gradually, aided in great measure by the histopathologic findings...
  5. pmc Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47)
    Craig L Slingluff
    University of Virginia, Charlottesville, VA 22908, USA
    Clin Cancer Res 19:3611-20. 2013
    ..A CTEP-sponsored phase II trial was conducted to evaluate safety and clinical activity of combination therapy with CCI-779 (temsirolimus) and bevacizumab in patients with advanced melanoma...
  6. pmc Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma
    Gulsun Erdag
    Department of Pathology, University of Virginia, Charlottesville, Virginia 22908, USA
    Cancer Res 72:1070-80. 2012
    ..These findings are important, not only by revealing how the immune microenvironment can affect outcomes but also because they reveal characteristics that may help improve individualized therapy for patients with metastatic melanoma...
  7. doi request reprint Locally invasive dermal squamomelanocytic tumor with matrical differentiation: a peculiar case with review of the literature
    Nemanja Rodic
    Department of Pathology, Johns Hopkins Hospital, Baltimore, MD 21205, USA
    Am J Dermatopathol 35:e72-6. 2013
    ..Most notable feature of this case is focal matrical differentiation and locally invasive tumor growth, characterized by multifocal perineural invasion...
  8. ncbi request reprint Solitary fibrous tumors of the skin: a clinicopathologic study of 10 cases and review of the literature
    Gulsun Erdag
    Department of Pathology, Georgetown University Medical Center, Washington, DC, USA
    J Cutan Pathol 34:844-50. 2007
    ..SFT of the skin appears to be a 'borderline' neoplasm that only uncommonly recurs. Immunoreactivity for CD-34, - especially together with bcl-2 or CD-99, or both - is helpful in identifying this tumor...
  9. pmc VEGFR-2 expression in human melanoma: revised assessment
    Kerrington R Molhoek
    Department of Surgery, University of Virginia School of Medicine, Charlottesville, VA, USA
    Int J Cancer 129:2807-15. 2011
    ..Our results show that relatively few melanoma cells (<10%) express detectable levels of VEGFR-2, and therefore, the majority of patients with melanoma are unlikely to benefit from antiproliferative effects of anti-VEGF therapy...